|
PF-56787 |
HYNDRIAX 20 mg Cápsulas blandas |
2024-06-05 |
|
Roemmers de Centroamerica, S.A. |
Brasil
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56806 |
HYNDRIAX 10 mg Cápsula blanda |
2024-06-11 |
|
Roemmers de Centroamerica, S.A. |
Brasil
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58217 |
CITABICLOS 25, 25 mg Cápsulas Blandas |
2025-05-07 |
|
Germed Farmaceutica Ltda. |
Brasil
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58164 |
CITABICLOS 100, 100 mg Cápsulas Blandas |
2025-04-22 |
|
Germed Farmaceutica Ltda. |
Brasil
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57147 |
CITABICLOS 50, 50 mg Cápsulas Blandas |
2024-08-29 |
|
Germed Farmaceutica Ltda. |
Brasil
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52731 |
DACTINOMICINA Getwell 500 mcg Polvo para uso parenteral |
2021-04-19 |
|
Getwell Pharmaceuticals |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52890 |
ETOPOSIDO Getwell 20 mg/mL Solución inyectable |
2026-05-26 |
|
Getwell Pharmaceuticals |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52898 |
CLORHIDRATO DE DOXORRUBICINA Getwell 2 mg/mL Suspensión liposomada pegilada inyectable |
2026-05-26 |
|
Getwell Pharmaceuticals |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55161 |
L-ASPARAGINASA Getwell 10,000 UI Polvo liofilizado para solución inyectable |
2023-04-09 |
|
Getwell Pharmaceuticals |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55476 |
BORTEZOMIB Getwell 3.5 mg Polvo liofilizado para uso parenteral |
2023-07-11 |
|
Getwell Pharmaceuticals |
India
|
Futura |
Qadira |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|